EVO756 in patients with chronic inducible urticaria (CIndU)
We are currently recruiting participants 18 to 65 years, with a medical diagnosis of chronic hives that is triggered by touch or cold temperatures. We are investigating the safety and effectiveness of a new treatment called EVO756 to see if it can reduce hives in people with CIndU. Participation will last for approximately 10 weeks, including screening and follow-up. Patients will be asked to visit their study site approximately 7 times. There will be no cost to you for taking part in this study and you will be provided with all study medication, examinations and medical care related to the study. Complete the short questionnaire to see if you qualify for the study!
* Las preguntas con un asterisco rojo son obligatorias
Empezar cuestionario
